The global pandemic produced a slow-burning mass trauma event with huge implications for today’s employers.
In this case study, learn how a large pharmaceutical company partnered with meQ to embed resilience in its culture — and measurably improve the mental wellbeing of its people.
GET THE
CASE STUDY
WHAT HAPPENS WHEN LEADERS COMMIT TO
WORKFORCE RESILIENCE:
74%
improvement in stress management
40%
improvement in work-life balance
Company leadership was committed to get to the root of employee mental health risks. With meQ, they did — and the risks dropped.
